Sglt2i drugs list

o SGLT2i's: empagliflozin and dapagliflozin (canagliflozin and ertugliflozin The following chart is a list of oral and injectable diabetes medications

Dulaglutide / Trulicity (GLP1-RA); Empagliflozin / Jardiance (SGLT2i); Liraglutide / Victoza (GLP1-RA) Empagliflozin / Jardiance (SGLT2i); Sitagliptin

SGLT2i separately. In addition, to include new drugs in Thailand's National List of Essential Medicines (NLEM), it is imperative to conduct

When Trulicity is added to existing metformin and/or pioglitazone therapy, the current dose of metformin and/or pioglitazone can be continued. SGLT2i When Trulicity is added to existing metformin and/or sodium-glucose co-transporter 2 inhibitor (SGLT2i) therapy, the current dose of metformin and/or SGLT2i can be continued.

Antihyperglycemic medication use was assessed on the drug class level including metformin, sulfonylureas, thiazolidinediones, SGLT2i

Four SGLT2i are currently commercially available in many countries: canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin. SGLT2i reduce glycated

Recommendation for addition of an SGLT2i (or GLP-1RA where SGLT2i is not tolerated or contraindicated) to other glucose lowering medication(s) in adults

SGLT2 inhibitors (SGLT2i) are new drugs for patients with heart failure (HF) irrespective of diabetes. However, the mechanisms of SGLT2i in HF remain elusive. This article discusses the current clinical evidence for using SGLT2i in different types of heart failure and provides an overview about the possible underlying mechanisms.

If a patient is already on metformin and/or sodium-glucose co-transporter 2 inhibitor (SGLT2i) therapy, the current dose of metformin and/or SGLT2i can be